Published in Eur J Oral Sci on April 01, 1997
Interactions of adiponectin and lipopolysaccharide from Porphyromonas gingivalis on human oral epithelial cells. PLoS One (2012) 0.92
Discovering medical conditions associated with periodontitis using linked electronic health records. J Clin Periodontol (2013) 0.88
Characteristics of inflammation common to both diabetes and periodontitis: are predictive diagnosis and targeted preventive measures possible? EPMA J (2010) 0.87
Increased and correlated expression of connective tissue growth factor and transforming growth factor beta 1 in surgically removed periodontal tissues with chronic periodontitis. J Periodontal Res (2014) 0.84
Changes in Transforming Growth Factor-β1 in Gingival Crevicular Fluid of Patients with Chronic Periodontitis Following Periodontal Flap Surgery. J Clin Diagn Res (2015) 0.79
Effects of phosphated titanium and enamel matrix derivatives on osteoblast behavior in vitro. Int J Oral Maxillofac Implants (2007) 0.78
Effect of phosphate treatment of Acid-etched implants on mineral apposition rates near implants in a dog model. Int J Oral Maxillofac Implants (2010) 0.77
Local inflammation exacerbates cyclosporine a-induced gingival overgrowth in rats. Inflammation (2008) 0.76
Increased oxygen exposure alters collagen expression and tissue architecture during ligature-induced periodontitis. J Periodontal Res (2016) 0.75
N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A (1975) 9.24
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol (1999) 5.58
Macrophages as a source of HIV during opportunistic infections. Science (1997) 3.92
Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. J Exp Med (1998) 3.56
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis. Cell Immunol (1984) 3.36
TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity (2001) 3.20
Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol (1978) 3.16
Collagenase production by endotoxin-activated macrophages. Proc Natl Acad Sci U S A (1974) 3.05
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med (1993) 2.98
Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest (1995) 2.95
Collagenase production by lymphokine-activated macrophages. Science (1975) 2.64
Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today (1989) 2.56
Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med (2000) 2.48
Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood (1997) 2.41
Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. J Immunol (1979) 2.39
Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol (1991) 2.39
Role of a peptidase in phagocyte chemotaxis. Proc Natl Acad Sci U S A (1976) 2.38
Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol (1991) 2.23
Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med (1990) 2.19
Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest (1991) 2.18
Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta. J Clin Invest (1991) 2.11
Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. J Clin Invest (1984) 2.10
Transforming growth factor beta: a matter of life and death. J Leukoc Biol (1994) 1.97
The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat. Comparative studies in arthritis resistant and susceptible inbred rat strains. Arthritis Rheum (1983) 1.83
Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J Exp Med (2001) 1.82
Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel of hypervirulent strain. J Infect Dis (1990) 1.77
Intestinal macrophages and response to microbial encroachment. Mucosal Immunol (2010) 1.76
Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats. J Clin Invest (1985) 1.73
Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol (1999) 1.70
Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest (1997) 1.67
NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment. Ann Intern Med (1984) 1.61
Macrophage production of fibronectin, a chemoattractant for fibroblasts. J Immunol (1981) 1.58
Induction of guinea pig B-cell lymphokine synthesis by mitogenic and nonmitogenic signals to Fc, Ig, and C3 receptors. J Exp Med (1974) 1.53
Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol (1996) 1.51
Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med (1999) 1.49
In vitro studies of a chemotactic lymphokine in the guinea pig. Int Arch Allergy Appl Immunol (1974) 1.46
Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity. J Immunol (1987) 1.40
Modulation of fibroblast growth by a lymphokine of human T cell continuous T cell line origin. J Immunol (1983) 1.39
Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta. J Immunol (1991) 1.33
Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun (1991) 1.32
The role of macrophages in the production of lymphokines by T and B lymphocytes. J Immunol (1975) 1.29
T lymphocyte-dependent evolution of bacterial cell wall-induced hepatic granulomas. J Immunol (1986) 1.29
Apoptosis in human monocytes: possible role in chronic inflammatory diseases. J Periodontol (1993) 1.26
Hepatic fibrosis in schistosomiasis: egg granulomas secrete fibroblast stimulating factor in vitro. Science (1978) 1.25
Inhibition by cyclosporin A of streptococcal cell wall-induced arthritis and hepatic granulomas in rats. Arthritis Rheum (1986) 1.25
IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol (1992) 1.24
Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages. J Clin Invest (1992) 1.24
The role of the oral environment in HIV-1 transmission. J Am Dent Assoc (1998) 1.24
Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc Natl Acad Sci U S A (1994) 1.23
Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J Immunol (1993) 1.23
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). II. Functional properties of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions. Cell Immunol (1984) 1.22
Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. J Immunol (1990) 1.22
Spontaneous production of fibroblast-activating factor(s) by synovial inflammatory cells. A potential mechanism for enhanced tissue destruction. J Exp Med (1985) 1.20
Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis (1990) 1.18
Substance P receptor-mediated chemotaxis of human monocytes. Peptides (1985) 1.18
Complement-induced histamine release from human basophils. I. Generation of activity in human serum. J Immunol (1975) 1.17
Co-expression of chemotactic ligand receptors on human peripheral blood monocytes. J Immunol (1987) 1.16
Fibroblast stimulation in schistosomiasis. I. Stimulation in vitro of fibroblasts by soluble products of egg granulomas. J Infect Dis (1981) 1.16
Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures. J Virol (1991) 1.14
Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics. J Clin Invest (1984) 1.11
Benzodiazepine receptor-mediated chemotaxis of human monocytes. Science (1985) 1.10
Oral delivery of group A streptococcal cell walls augments circulating TGF-beta and suppresses streptococcal cell wall arthritis. J Immunol (1998) 1.10
Partial IgA-deficiency with increased Th2-type cytokines in TGF-beta 1 knockout mice. J Immunol (1999) 1.08
Cytokines and neuropathology. Trends Pharmacol Sci (1992) 1.07
Dipyridamole potentiates the inhibition by 3'-azido-3'-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte-macrophages. Proc Natl Acad Sci U S A (1989) 1.05
Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG. J Immunol (1991) 1.04
Expression of interleukin 2 receptors by monocytes from patients with acquired immunodeficiency syndrome and induction of monocyte interleukin 2 receptors by human immunodeficiency virus in vitro. J Clin Invest (1990) 1.04
Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation. Ann Rheum Dis (2008) 1.03
Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J Clin Invest (1998) 1.03
Inhibition of in vitro lymphokine synthesis by glucocorticosteroids. J Immunol (1975) 1.03
Leukapheresis in rheumatoid arthritis. Association of clinical improvement with reversal of anergy. Arthritis Rheum (1983) 1.03
Cytokines and fibrosis. Clin Exp Rheumatol (1987) 1.03
Differential regulation of colony-stimulating factors and interleukin 2 production by cyclosporin A. Proc Natl Acad Sci U S A (1987) 1.02
Bacterial cell wall-induced hepatic granulomas. An in vivo model of T cell-dependent fibrosis. J Exp Med (1986) 1.02
Mediation of macrophage collagenase production by 3'-5' cyclic adenosine monophosphate. J Immunol (1980) 1.00
Impact of HIV-1 infection on VH3 gene repertoire of naive human B cells. J Immunol (2000) 0.99
Effects of transforming growth factor-beta deficiency on bone development: a Fourier transform-infrared imaging analysis. Bone (2002) 0.99
Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes. J Immunol (1992) 0.99
Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function. J Immunol (1990) 0.99
IL-4 antagonizes induction of Fc gamma RIII (CD16) expression by transforming growth factor-beta on human monocytes. J Immunol (1991) 0.96
The effect of complement depletion on wound healing. Am J Pathol (1974) 0.96
Selective elimination of HIV-1-infected cells with an interleukin-2 receptor-specific cytotoxin. Science (1991) 0.96
Autoimmune Sjögren's-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides. J Immunol (1996) 0.95
Inhibitors of reactive oxygen intermediates suppress bacterial cell wall-induced arthritis. J Immunol (1991) 0.95
Endotoxin administration to humans primes alveolar macrophages for increased production of inflammatory mediators. J Clin Immunol (1994) 0.95
Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo. J Exp Med (1993) 0.95
Differential mucosal susceptibility in HIV-1 transmission and infection. Adv Dent Res (2006) 0.95
Modulation of monocyte type I transforming growth factor-beta receptors by inflammatory stimuli. J Biol Chem (1991) 0.94
Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases. Microbes Infect (1999) 0.94
Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study. Ann Intern Med (1988) 0.94
Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection. J Infect Dis (1994) 0.94
Modulation of human immunodeficiency virus type 1 infection of human monocytes by IgA. J Infect Dis (1995) 0.94
Host immune factors regulating fibrosis. Ciba Found Symp (1985) 0.93
The role of lymphocytes and macrophages in the destruction of bone and collagen. Ann N Y Acad Sci (1975) 0.93
Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. J Immunol (2001) 0.93
Synergistic drug combinations in AIDS therapy. Dipyridamole/3'-azido-3'-deoxythymidine in particular and principles of analysis in general. Ann N Y Acad Sci (1990) 0.93